Media Pack
News

Current Edition

Volume 16 Issue 2
 
Developing an eCOA Device Supply Strategy: The Vital Considerations for a Global Clinical Trial
Special Features V8 I1

Developing an eCOA Device Supply Strategy: The Vital Considerations for a Global Clinical Trial

  In the last 10 years, many technologies have been introduced to the market which not only support overall trial management, but also help sponsors and CROs ach...
24 February 2016 Special Features V8 I1 | Therapeutics
Continue Reading →
Insights into Oncology Studies
Therapeutics

Insights into Oncology Studies

Of the 27 speciality drugs approved by the Food and Drug Administration in 2014, nine were approved for the treatment of cancer or cancer-related conditions. FDA appr...
24 February 2016 Therapeutics | Therapeutics V8 I1
Continue Reading →
Role of Telespirometry in Chronic Obstructive Pulmonary Disease Management: Remote, Serial Lung Function Assessments in Homecare, Primary-care and Clinical Trials
Therapeutics

Role of Telespirometry in Chronic Obstructive Pulmonary Disease Management: Remote, Serial Lung Function Assessments in Homecare, Primary-care and Clinical Trials

The development and perfection of the internet, wireless technology and the greatly increased electronic information flow make supporting diagnostic and therapeutic a...
24 February 2016 Therapeutics | Therapeutics V8 I1
Continue Reading →
The Key to Inspection Readiness: Using Your eTMF as a Process Too
Therapeutics

The Key to Inspection Readiness: Using Your eTMF as a Process Too

Any clinical team for a sponsor or contract research organisation (CRO) can relate to the long hours and sleepless nights leading up to the inspection of a trial m...
12 January 2016 Therapeutics
Continue Reading →
Industry and Academia Partnering to Advance Prevention and Treatment of Alzheimer’s Disease
Therapeutics

Industry and Academia Partnering to Advance Prevention and Treatment of Alzheimer’s Disease

According to current evidence, Alzheimer’s disease (AD) is a disease continuum with a 10-20-year pre-symptomatic phase preceding the onset of dementia. The Interna...
12 January 2016 Therapeutics
Continue Reading →
Burn Trauma: An Emerging Model for Acute Pain
Therapeutics

Burn Trauma: An Emerging Model for Acute Pain

Emphasis in acute pain studies has shifted to outcomes that go beyond “good pain relief” to reductions in the risk of developing chronic pain, acute medical condit...
12 January 2016 Therapeutics
Continue Reading →
Elevated HCG in Women of Non-Childbearing Potential with Diffuse Large B-Cell Lymphoma
Therapeutics

Elevated HCG in Women of Non-Childbearing Potential with Diffuse Large B-Cell Lymphoma

A positive test for β-hCG is used in clinical trials for pregnancy detection prior to entering the study and is indicated for women of a childbearing potential. Al...
12 January 2016 Therapeutics
Continue Reading →
Collaborative Drug Development for Rare Diseases
Therapeutics

Collaborative Drug Development for Rare Diseases

Patient groups are essential partners for clinical research as they are usually the most invested, and can therefore drive drug development. Often, patient groups foc...
12 February 2014 Therapeutics | Volume 6 Issue 1
Continue Reading →
Increasing Therapeutic Complexity in CNS Clinical Trials: The Need for Therapeutically Aligned Staff
Therapeutics

Increasing Therapeutic Complexity in CNS Clinical Trials: The Need for Therapeutically Aligned Staff

The recent rise in protocol complexity has been particularly evident in trials targeting CNS diseases, where, in the wake of some notable late-stage study failures in...
12 February 2014 Therapeutics | Volume 6 Issue 1
Continue Reading →
Arterial Stiffness and Rheumatoid Arthritis
Therapeutics

Arterial Stiffness and Rheumatoid Arthritis

Rheumatoid arthritis (RA) is associated with increased cardiovascular morbidity and mortality, while over the past few years, arterial stiffness has emerged as a new ...
12 February 2014 Therapeutics | Volume 6 Issue 1
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte